lilly glp 1 agonist Diabetes Patients Also Struggle to Access GLP-1 Agonists Orforglipron: Eli Lilly's New Oral

doi: 10.1007/s00125-017-4342-z

I don't really think of it though as like fluoride in the water it's not really meant for public health, and that's why public health has to be a partner with clinical medicine

doi: 10.1016/j.bbrc.2018.10.197 66 WuXLiSXuePLiY

Why It Matters Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan

Pharmacol Res (2020) 152:104615